首页> 外文期刊>Free radical research >Mn porphyrin-based SOD mimic, MnTnHex-2-PyP5+, and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-kappa B pathways
【24h】

Mn porphyrin-based SOD mimic, MnTnHex-2-PyP5+, and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-kappa B pathways

机译:基于锰卟啉的SOD模拟物MnTnHex-2-PyP5 +和非SOD模拟物MnTBAP(3-)通过NF-κB途径抑制大鼠脊髓缺血/再灌注损伤

获取原文
获取原文并翻译 | 示例
       

摘要

Herein we have demonstrated that both superoxide dismutase (SOD) mimic, cationic Mn(III) meso-tetrakis (N-n-hexylpyridinium-2-yl) porphyrin (MnTnHex-2-PyP5+), and non-SOD mimic, anionic Mn(III) meso-tetrakis(4-carboxylatophenyl) porphyrin (MnTBAP(3-)), protect against oxidative stress caused by spinal cord ischemia/reperfusion via suppression of nuclear factor kappa B (NF-kappa B) pro-inflammatory pathways. Earlier reports showed that Mn(III) N-alkylpyridylporphyrins were able to prevent the DNA binding of NF-kappa B in an aqueous system, whereas MnTBAP(3-) was not. Here, for the first time, in a complex in vivo system-animal model of spinal cord injury-a similar impact of MnTBAP(3-), at a dose identical to that of MnTnHex-2-PyP5+, was demonstrated in NF-kappa B downregulation. Rats were treated subcutaneously at 1.5 mg/kg starting at 30 min before ischemia/ reperfusion, and then every 12 h afterward for either 48 h or 7 days. The anti-inflammatory effects of both Mn porphyrins (MnPs) were demonstrated in the spinal cord tissue at both 48 h and 7 days. The downregulation of NF-kappa B, a major pro-inflammatory signaling protein regulating astrocyte activation, was detected and found to correlate well with the suppression of astrogliosis (as glial fibrillary acidic protein) by both MnPs. The markers of oxidative stress, lipid peroxidation and protein carbonyl formation, were significantly reduced by MnPs. The favorable impact of both MnPs on motor neurons (Tarlov score and inclined plane test) was assessed. No major changes in glutathione peroxidase- and SOD-like activities were demonstrated, which implies that none of the MnPs acted as SOD mimic. Increasing amount of data on the reactivity of MnTBAP(3-) with reactive nitrogen species (RNS) (center dot NO/HNO/ONOO-) suggests that RNS/MnTBAP(3-)-driven modification of NF-kappa B protein cysteines may be involved in its therapeutic effects. This differs from the therapeutic efficacy of MnTnHex-2-PyP5+ which presumably occurs via reactive oxygen species and relates to NF-kappa B thiol oxidation; the role of RNS cannot be excluded.
机译:在本文中,我们证明了超氧化物歧化酶(SOD)模拟阳离子型Mn(III)中四(Nn-己基吡啶-2-基)卟啉(MnTnHex-2-PyP5 +)和非SOD模拟阴离子型Mn(III)介孔四(4-羧基苯基)卟啉(MnTBAP(3-))通过抑制核因子kappa B(NF-kappa B)促炎性途径保护免受脊髓缺血/再灌注引起的氧化应激。较早的报道表明,Mn(III)N-烷基吡啶基卟啉能够阻止水性系统中NF-κB的DNA结合,而MnTBAP(3-)则不能。在此,首次在复杂的体内系统-脊髓损伤动物模型中,在NF-κB中证实了与MnTBnHex-2-PyP5 +相同剂量的MnTBAP(3-)的相似作用。 B下调。从缺血/再灌注前30分钟开始,以1.5 mg / kg的剂量对大鼠进行皮下治疗,然后每12 h进行48 h或7天。两种锰卟啉(MnPs)的抗炎作用在48小时和7天均在脊髓组织中得到证实。 NF-κB是调节星形胶质细胞激活的主要促炎信号蛋白,其下调被检测到,并发现与两种MnPs抑制星形胶质细胞增生(神经胶质原纤维酸性蛋白)密切相关。 MnPs显着降低了氧化应激,脂质过氧化和蛋白质羰基形成的标记。评估了两种MnP对运动神经元的有利影响(Tarlov评分和斜面试验)。没有显示出谷胱甘肽过氧化物酶和SOD样活性的重大变化,这表明MnPs均不充当SOD模拟物。关于MnTBAP(3-)与活性氮(RNS)(中心点NO / HNO / ONOO-)的反应性的数据越来越多,这表明RNS / MnTBAP(3-)驱动的NF-κB蛋白半胱氨酸修饰可能参与其治疗作用。这不同于MnTnHex-2-PyP5 +的治疗功效,后者可能是通过活性氧而发生的,并且与NF-κB硫醇的氧化有关。 RNS的作用不能被排除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号